Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies
Stella E. Lee, Claire Hopkins, Joaquim Mullol, et al.
Allergy (2022) Vol. 77, Iss. 7, pp. 2211-2221
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 159
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis
Harsha H. Kariyawasam, Deepak P. Chandrasekharan, T Jacques, et al.
Rhinology Journal (2023) Vol. 61, Iss. 2, pp. 98-107
Open Access | Times Cited: 26
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access | Times Cited: 1
Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Masato Tamari, Aaron Ver Heul
Allergology International (2025)
Open Access | Times Cited: 1
Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
Elena Cantone, Eugenio De Corso, Filippo Ricciardiello, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1215-1215
Open Access | Times Cited: 36
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients
Matteo Alicandri‐Ciufelli, Daniele Marchioni, Carlotta Pipolo, et al.
The Laryngoscope (2023) Vol. 134, Iss. 4, pp. 1556-1563
Open Access | Times Cited: 15
Comparative short‐term efficacy of endoscopic sinus surgery and biological therapies in chronic rhinosinusitis with nasal polyps: A network meta‐analysis
Jiani Chen, Huan Wang, Chen Zhang, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 13
Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study
Ignazio La Mantia, Egle Grigaliute, Martina Ragusa, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 1, pp. 219-226
Closed Access | Times Cited: 13
ChatGPT’s Skills in Statistical Analysis Using the Example of Allergology: Do We Have Reason for Concern?
Michał Ordak
Healthcare (2023) Vol. 11, Iss. 18, pp. 2554-2554
Open Access | Times Cited: 11
Patient-centered outcomes for clinical trials in chronic rhinosinusitis with or without nasal polyps and allergic fungal rhinosinusitis
Brittany Klooster, Kaitlin Chatterton, Nazifa Ibrahim, et al.
Journal of Patient-Reported Outcomes (2025) Vol. 9, Iss. 1
Open Access
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
Hyun Ji Lee, Yu Ri Woo, Young Bok Lee, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv40704-adv40704
Open Access
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Correlation Between Smell Recovery and Nasal Polyp Score in Patients Treated with Dupilumab: A Real-Life Retrospective, Observational, Monocentric Study
Giovanna Stilo, Giuliano Messina, Carmelo Lo Faro, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 5, pp. 164-164
Open Access
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
Jorge Máspero, Asif Khan, Carl Philpott, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 323-332
Open Access | Times Cited: 10
The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumab
Sebastian Ferri, Carlo Montagna, Marta Casini, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 1, pp. 69-75
Closed Access | Times Cited: 9
The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
Nicholas J. Campion, Jonas Brugger, Aldine Tu, et al.
Journal of Otolaryngology - Head and Neck Surgery (2023) Vol. 52, Iss. 1
Open Access | Times Cited: 9
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 3
The IL‐4–IL‐4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell
Yannis Hara, Mithilesh Kumar Jha, Jeremy Huang, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 440-461
Open Access | Times Cited: 3
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps
Claire Hopkins, Joaquim Mullol, Asif Khan, et al.
Otolaryngology (2023) Vol. 170, Iss. 4, pp. 1173-1182
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top